Abstract

Purpose Single-isocenter, volumetric modulated arc therapy (VMAT) stereotactic radiosurgery (SRS) for multiple brain metastases (multi-mets) can deliver highly conformal dose distributions and reduce overall patient treatment time compared to other techniques. However, treatment planning for multi-met cases is highly complex due to variability in numbers and sizes of brain metastases, as well as their relative proximity to organs-at-risk (OARs). The purpose of this study was to automate the VMAT planning of multi-met cases through a knowledge-based planning (KBP) approach that adapts single target SRS dose predictions to multiple target predictions. Methods Using a previously-published artificial neural network (ANN) KBP system trained on single-target, linac-based SRS plans, 3D dose distribution predictions for multi-met patients were obtained by treating each brain lesion as a solitary target and subsequently combining individual dose predictions into a single distribution. Spatial dose distributions di(r→) for each of the i=1..N lesions were merged using the combination function d(r→)=∑iNdin(r→)1/n. The optimal value of n was determined by minimizing root-mean squared (RMS) difference between clinical multi-met plans and predicted dose per unit length along the line profile joining each lesion in the clinical cohort. The gradient measure (GM=[3/4π]1/3V50%1/3−V100%1/3) is the primary quality metric for SRS plan evaluation at our institution and served as the main comparative metric between clinical plans and the KBP results. A total of 41 previously-treated multi-met plans, with target numbers ranging from N=2-10, were used to validate the ANN predictions and subsequent KBP auto-planning routine. Fully-deliverable KBP plans were developed by converting predicted dose distribution into patient-specific optimization objectives for the clinical treatment planning system (TPS). Plan parity was maintained through identical arc configuration and target normalization. Overall plan quality improvements were quantified by calculating the difference between SRS quality metrics (QMs): ΔQM=QMclinical-QMKBP. In addition to GM, investigated QMs were: volume of brain receiving ≥10 Gy (V10Gy), volume of brain receiving ≥5 Gy (ΔV5Gy), heterogeneity index (HI) , dose to 0.1 cc of the brainstem (D0.1cc), dose to 1% of the optic chiasm (D1%), and inter-lesion dose (DIL). In addition to this quantitative analysis, overall plan quality was assessed via blinded plan comparison of the manual and KBP treatment plans by SRS-specializing physicians. Results A dose combination factor of n=8 yielded an integrated dose profile RMS difference of 2.9% across the 41-patient cohort. Multi-met dose predictions exhibited ΔGM=0.07±0.10cm against the clinical sample, implying either further normal tissue sparing was possible or that dose predictions were slightly overestimating achievable dose gradients. The latter is the more likely explanation, as this bias vanished when dose predictions were converted to deliverable KBP plans ΔGM=0.00±0.08cm. Remaining QMs were nearly identical or showed modest improvements in the KBP sample. Equivalent QMs included: ΔV10Gy=0.37±3.78cc, ΔHI=0.02±0.08 and ΔDIL=-2.22±171.4cGy. The KBP plans showed a greater degree of normal tissue sparing as indicated by brain ΔV5Gy=4.11±24.05cc, brainstem ΔD0.1cc =42.8±121.4cGy, and chiasm ΔD1% =50.8±83.0cGy. In blinded review by SRS-specializing physicians, KBP generated plans were deemed equivalent or superior in 32/41(78.1%) of the cases. Conclusion Heuristic KBP-driven automated planning in linac-based, single-isocenter treatments for multiple brain metastases maintained or exceeded overall plan quality. This article is protected by copyright. All rights reserved.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.